Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics

France-based pharma company Servier is acquiring the muscular dystrophy business of Edgewise Therapeutics as part of a revenue growth strategy in oncology and neurology. The deal brings an Edgewise drug in clinical development for two rare neuromuscular disorders with limited treatment options. The post Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise…

Read More

Rethinking Masculinity in Men’s Health

Too many men ignore symptoms until they can no longer function. We end up seeing them in the emergency room, sometimes with late-stage cancer or uncontrolled chronic disease that could have been managed if addressed earlier. The post Rethinking Masculinity in Men’s Health appeared first on MedCity News.

Read More

When the Doctor Needs a Checkup

He was a surgical oncologist at a hospital in a Southern city, a 78-year-old whose colleagues had begun noticing troubling behavior in the operating room. During procedures, he seemed “hesitant, not sure of how to go on to the next step without being prompted” by assistants, said Mark Katlic, director of the Aging Surgeon Program…

Read More